References

1. Dena Ettehad, Schaaf HS, James Seddon A, Graham Cooke S, Nathan Ford. Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2012 Jun; 12(6): 449-56. PubMed | Google Scholar


2. Nelson LJ, Wells CD. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis. 2004 May; 8(5): 636-47. PubMed | Google Scholar


3. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. World Health Organization. Available from: http://www.whqlibdoc.who.int.sci-hub.org/publications/2010/9789241599191_eng.pdf. [Last accessed on 2011 May 05]. Google Scholar


4. Simon Schaaf H, Marais BJ. Management of multidrug-resistant tuberculosis in children: a survival guide for Paediatricians. Paediatric Respiratory Reviews. 2011; 12(1): 31-38. PubMed | Google Scholar


5. World Health Organization. Anti-tuberculosis drug resistance in the world. Fourth Global Report. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 2002-2007. Available from: http://www.who.int.sci-hub.org/tb/publications/2008/drs_report4_26feb08.pdf. [Last accessed on 2011 May 05]. Google Scholar


6. Seddon JA, Hesseling AC, Godfrey-Faussett P, Schaaf HS. High treatment success in children treated for multidrug-resistant tuberculosis: an observational cohort study. Thorax. 2014 May; 69(5): 458-64. PubMed | Google Scholar


7. Furin JJ, Mitnick CD, Shin SS et al. Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2001 Jul; 5(7): 648-55. PubMed | Google Scholar